RSS-Feed abonnieren

DOI: 10.1055/s-0045-1809159
TSLP Production Induced by Poly(I:C) Stimulation Increased in the Presence of Th2 Cytokines in Patients with Severe ECRS
Autoren
Funding This research was funded by JSPS KAKENHI (17K11367, 23K08975), Toho University school of medicine Yanase Takeshi Scholarship Fund, Toho University school of medicine Nukada Scholarship Fund, a project research grant from Toho University an initiative to realize diversity in the research environment, The Research Promotion Grant from Toho University Graduate School of Medicine (Grant/Award Number: ‘19-02’), Toho University School of Medicine Project Research funding (Grant/Award Number: ‘28-22’).
Abstract
Introduction
In patients with eosinophilic chronic rhinosinusitis (ECRS), viral infection of the upper respiratory tract tends to exacerbate the symptoms.
Objective
To clarify the effect of the cytokines during viral infection in ECRS patients, we investigated the production of thymic stromal lymphopoietin (TSLP) in the sinus mucosa of ECRS patients in the presence of polyinosinic: polycytidylic acid, or poly(I:C), which mimics viral infection, with or without interleukin-4 (IL-4) or IL-13.
Methods
The ECRS patients were classified into mild, moderate, and severe groups based on the scoring system of the Japanese Epidemiological Study of Refractory Eosinophilic Chronic Rhinosinusitis (JESREC). We obtained paranasal sinus mucosa from patients with ECRS through endoscopic sinus surgery, as well as nasal epithelial cells. The cells were stimulated with poly(I:C) in the presence or absence of IL-4 or IL-13. The TSLP concentrations in the culture supernatants were measured using enzyme-linked immunosorbent assay (ELISA) after 24 hours of stimulation.
Results
Nasal epithelial cells from patients with ECRS or healthy controls produced TSLP upon stimulation with poly(I:C) alone, and the addition of IL-4 or IL-13 increased TSLP production. Notably, the increase in poly(I:C)-induced TSLP production from nasal epithelial cells in the presence of IL-4 or IL-13 was greater among the severe group compared to the other groups.
Conclusion
In the sinus mucosa of patients with severe ECRS, TSLP production was enhanced more when poly(I:C) stimulation was combined with IL-4 or IL-13 stimulation. Thus, the Th2-skewed condition of the sinus mucosa during viral infection in patients with more severe ECRS may accelerate disease exacerbation.
Ethic Number
The study protocol was approved by the Ethics Committee of Faculty of Medicine, Toho University (approval number: 27028, A18086_27028).
Author's Contributions
Akiko Inoue contributed to the study idea; participated in the study design, cell culture, stimulation, and data analysis: wrote the initial draft of the manuscript. Yuriko Tanaka contributed to the evaluation of examination and wrote the manuscript based on the suggestion. Hidehito Matsui and Akira Fukuo contributed to the collecting samples. Motonari Kondo contributed to the study idea, supervised experiments and wrote the manuscript. Kota Wada contributed to the study idea and study design, collected samples, and clinically wrote the manuscript and assisted with data analysis. All authors discussed the results and commented the manuscript.
Publikationsverlauf
Eingereicht: 28. November 2024
Angenommen: 24. März 2025
Artikel online veröffentlicht:
10. September 2025
© 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution 4.0 International License, permitting copying and reproduction so long as the original work is given appropriate credit (https://creativecommons.org/licenses/by/4.0/)
Thieme Revinter Publicações Ltda.
Rua Rego Freitas, 175, loja 1, República, São Paulo, SP, CEP 01220-010, Brazil
Akiko Inoue, Yuriko Tanaka, Hidehito Matsui, Akira Fukuo, Motonari Kondo, Kota Wada. TSLP Production Induced by Poly(I:C) Stimulation Increased in the Presence of Th2 Cytokines in Patients with Severe ECRS. Int Arch Otorhinolaryngol 2025; 29: s00451809159.
DOI: 10.1055/s-0045-1809159
-
References
- 1 Fokkens WJ, Lund VJ, Mullol J, Bachert C, Alobid I, Baroody F. et al. EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists. Rhinology 2012; 50 (01) 1-12 10.4193/Rhino12.000
- 2 Ikeda K, Shiozawa A, Ono N, Kusunoki T, Hirotsu M, Homma H. et al. Subclassification of chronic rhinosinusitis with nasal polyp based on eosinophil and neutrophil. Laryngoscope 2013; 123 (11) E1-E9 10.1002/lary.24154
- 3 Cao P-P, Li H-B, Wang B-F, Wang S-B, You X-J, Cui Y-H. et al. Distinct immunopathologic characteristics of various types of chronic rhinosinusitis in adult Chinese. J Allergy Clin Immunol 2009; 124 (03) 478-484 , 484.e1–484.e2 10.1016/j.jaci.2009.05.017
- 4 Kim JW, Hong SL, Kim YK, Lee CH, Min YG, Rhee CS. Histological and immunological features of non-eosinophilic nasal polyps. Otolaryngol Head Neck Surg 2007; 137 (06) 925-930 10.1016/j.otohns.2007.07.036
- 5 Inoue A, Tanaka Y, Ohira S, Matsuura K, Kondo M, Wada K. High CD4 + T-Cell/B-Cell Ratio in the Paranasal Sinus Mucosa of Patients with Eosinophilic Chronic Rhinosinusitis. Int Arch Otorhinolaryngol 2021; 25 (03) e416-e420 10.1055/s-0040-1715587
- 6 Tokunaga T, Sakashita M, Haruna T, Asaka D, Takeno S, Ikeda H. et al. Novel scoring system and algorithm for classifying chronic rhinosinusitis: the JESREC Study. Allergy 2015; 70 (08) 995-1003 10.1111/all.12644
- 7 Fokkens WJ, Lund VJ, Hopkins C, Hellings PW, Kern R, Reitsma S. et al. European Position Paper on Rhinosinusitis and Nasal Polyps 2020. Rhinology 2020; 58 (Suppl S29): 1-464 10.4193/Rhin20.600
- 8 Oka A, Hirano T, Yamaji Y, Ito K, Oishi K, Edakuni N. et al. Determinants of Incomplete Asthma Control in Patients with Allergic Rhinitis and Asthma. J Allergy Clin Immunol Pract 2017; 5 (01) 160-164 10.1016/j.jaip.2016.08.002
- 9 Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell 2006; 124 (04) 783-801 10.1016/j.cell.2006.02.015
- 10 Gill MA. The role of dendritic cells in asthma. J Allergy Clin Immunol 2012; 129 (04) 889-901 10.1016/j.jaci.2012.02.028
- 11 Matsumoto K, Inoue H. Viral infections in asthma and COPD. Respir Investig 2014; 52 (02) 92-100 10.1016/j.resinv.2013.08.005
- 12 Alexopoulou L, Holt AC, Medzhitov R, Flavell RA. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 2001; 413 (6857): 732-738 10.1038/35099560
- 13 Choe J, Kelker MS, Wilson IA. Crystal structure of human toll-like receptor 3 (TLR3) ectodomain. Science 2005; 309 (5734): 581-585 10.1126/science.1115253
- 14 Soumelis V, Reche PA, Kanzler H, Yuan W, Edward G, Homey B. et al. Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP. Nat Immunol 2002; 3 (07) 673-680 10.1038/ni805
- 15 Ito T, Wang YH, Duramad O, Hori T, Delespesse GJ, Watanabe N. et al. TSLP-activated dendritic cells induce an inflammatory T helper type 2 cell response through OX40 ligand. J Exp Med 2005; 202 (09) 1213-1223 10.1084/jem.20051135
- 16 Corry DB, Folkesson HG, Warnock ML, Erle DJ, Matthay MA, Wiener-Kronish JP, Locksley RM. Interleukin 4, but not interleukin 5 or eosinophils, is required in a murine model of acute airway hyperreactivity. J Exp Med 1996; 183 (01) 109-117 10.1084/jem.183.1.109
- 17 Grünig G, Warnock M, Wakil AE, Venkayya R, Brombacher F, Rennick DM. et al. Requirement for IL-13 independently of IL-4 in experimental asthma. Science 1998; 282 (5397): 2261-2263 10.1126/science.282.5397.2261
- 18 Rothman P, Lutzker S, Cook W, Coffman R, Alt FW. Mitogen plus interleukin 4 induction of C epsilon transcripts in B lymphoid cells. J Exp Med 1988; 168 (06) 2385-2389 10.1084/jem.168.6.2385
- 19 Berton MT, Uhr JW, Vitetta ES. Synthesis of germ-line gamma 1 immunoglobulin heavy-chain transcripts in resting B cells: induction by interleukin 4 and inhibition by interferon gamma. Proc Natl Acad Sci U S A 1989; 86 (08) 2829-2833 10.1073/pnas.86.8.2829
- 20 Esser C, Radbruch A. Rapid induction of transcription of unrearranged S gamma 1 switch regions in activated murine B cells by interleukin 4. EMBO J 1989; 8 (02) 483-488 10.1002/j.1460-2075.1989.tb03401.x
- 21 Kim DK, Kang SI, Kong IG, Cho YH, Song SK, Hyun SJ. et al. Two-Track Medical Treatment Strategy According to the Clinical Scoring System for Chronic Rhinosinusitis. Allergy Asthma Immunol Res 2018; 10 (05) 490-502 10.4168/aair.2018.10.5.490
- 22 Wang YH, Ito T, Wang YH, Homey B, Watanabe N, Martin R. et al. Maintenance and polarization of human TH2 central memory T cells by thymic stromal lymphopoietin-activated dendritic cells. Immunity 2006; 24 (06) 827-838 10.1016/j.immuni.2006.03.019
- 23 Hirota T, Takahashi A, Kubo M, Tsunoda T, Tomita K, Doi S. et al. Genome-wide association study identifies three new susceptibility loci for adult asthma in the Japanese population. Nat Genet 2011; 43 (09) 893-896 10.1038/ng.887
- 24 Nakayama T, Hirota T, Asaka D, Sakashita M, Ninomiya T, Morikawa T. et al. A genetic variant near TSLP is associated with chronic rhinosinusitis with nasal polyps and aspirin-exacerbated respiratory disease in Japanese populations. Allergol Int 2020; 69 (01) 138-140 10.1016/j.alit.2019.06.007
- 25 Bachert C, Han JK, Desrosiers M, Hellings PW, Amin N, Lee SE. et al. Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials. Lancet 2019; 394 (10209): 1638-1650 10.1016/S0140-6736(19)31881-1
- 26 Menzies-Gow A, Corren J, Bourdin A, Chupp G, Israel E, Wechsler ME. et al. Tezepelumab in Adults and Adolescents with Severe, Uncontrolled Asthma. N Engl J Med 2021; 384 (19) 1800-1809 10.1056/NEJMoa2034975
- 27 Grossman J. One airway, one disease. Chest 1997; Feb; 111 (2 Suppl): 11S-16S . PMID: 9042022

